"我从小生长在云南的大山里，这里除了山还是山。拼搏16年，终于圆梦985高校读博士研究生，却不幸患上胃癌晚期。"近日，23岁的张睿在 社交平台分享了自己的抗癌历程，其坎坷的经历和面对病魔的坚韧，引发了众多网友关注与心疼。 据红星新闻2月27日报道，张睿的家在云南昭通市巧家县农村。2020年，他以650多分的高考成绩考入中山大学，2024年本科毕业后成功保研， 开启五年直博学业。 2025年7月，张睿出现胃部发胀、进食困难，同时伴有腰痛症状，就医检查后被确诊为胃癌晚期。 目前，他已接受十多次化疗，身体因此急剧消瘦，体重一度下降30多斤。所幸经过大半年的治疗，他的病情已暂时趋于稳定。 张睿坦言，进入大学后，自己生活作息不规律，吃饭更是饥一顿饱一顿，每次错过食堂饭点，只能在外购买食物。压力和不良情绪可能成为疾 病的诱因。 专家：临床发现年轻胃癌患者比例相对增加 年轻人应注重生活方式干预 据央广网2月25日报道，最新数据显示，我国胃癌新发病例约为35.9万例，其发病率高居我国恶性肿瘤第3位，已成为威胁国民生命健康的主要 恶性肿瘤之一。 复旦大学附属中山医院肿瘤内科主任刘天舒指出，近年来在临床中发现年轻胃癌患者比例相对 ...

Group 1 - The core message emphasizes the increasing risk of diabetes among working-age adults, with approximately 70% of the 589 million global diabetes patients being of working age [1] - A study published in The Lancet indicates that sitting for more than 6 hours a day increases the risk of chronic diseases by 26.7%, highlighting the negative impact of prolonged sedentary behavior on glucose metabolism [3] - The relationship between fatty liver disease and diabetes is critical, as insulin resistance caused by high blood sugar can lead to fatty liver, which in turn exacerbates blood sugar levels [5] Group 2 - Warning signs of prediabetes include fasting blood sugar levels reaching or exceeding 5.6 mmol/L, with specific thresholds indicating prediabetes that should prompt medical attention [7] - Dietary recommendations include the "fist rule" for portion sizes, emphasizing whole grains, protein, and vegetables while limiting oils, and the importance of avoiding misleading "sugar-free" products [9] - Regular physical activity is advised, with recommendations for aerobic and resistance training combined for a total of around 150 minutes per week [9]

Core Viewpoint - The article emphasizes the significant rise in global diabetes prevalence, projecting over 1.3 billion cases by 2050, with annual healthcare costs reaching $1.5 trillion. It highlights the critical link between obesity and diabetes, advocating for weight management as a key strategy for disease reversal [5][6][8]. Summary by Sections Global Diabetes Trends - The number of diabetes patients is expected to exceed 1.3 billion by 2050, with healthcare expenditures soaring to $1.5 trillion annually. Type 2 diabetes is recognized as a leading chronic epidemic of the century [5]. Weight Management and Diabetes Reversal - Scientific weight loss can effectively halt disease progression, with over 50% of patients reversing their condition after losing more than 10 kg. The 2025 American Diabetes Management Guidelines prioritize weight management as a first-line treatment for Type 2 diabetes [6][7]. New Clinical Guidelines - The American College of Lifestyle Medicine released the first global clinical guidelines for Type 2 diabetes and prediabetes, emphasizing lifestyle interventions as core strategies. Six key pillars are identified: scientific nutrition, regular exercise, stress management, quality sleep, healthy social connections, and avoidance of harmful substances [7][11]. Evidence of Reversal - Recent consensus redefines diabetes treatment, indicating that patients can achieve remission after stopping medication for over three months while maintaining stable blood sugar levels. This challenges the notion of lifelong medication dependency [8][9]. Impact of Weight Loss on Reversal Rates - Studies show that weight loss significantly increases the likelihood of diabetes reversal: an 86% reversal rate for those losing over 15 kg, 57% for 10-15 kg, and 34% for 5-10 kg [9][10]. Recommended Weight Loss Goals - Experts recommend a 10% weight loss target for diabetes remission, achievable through a daily caloric deficit of 500-1000 kcal. Various dietary patterns, including Mediterranean and low-carb diets, can support this goal [10]. Six Core Intervention Strategies 1. **Scientific Nutrition**: Focus on low glycemic index foods, balanced macronutrient intake, and sufficient dietary fiber [12]. 2. **Exercise Prescription**: At least 150 minutes of moderate-intensity aerobic exercise weekly, combined with resistance training [13]. 3. **Psychological Adjustment**: Address chronic stress through cognitive behavioral therapy and relaxation techniques [14]. 4. **Sleep Optimization**: Aim for 7-8 hours of quality sleep to enhance insulin sensitivity [15]. 5. **Social Support**: Strong social networks improve treatment adherence and metabolic outcomes [16]. 6. **Avoiding Harmful Substances**: Smoking cessation and alcohol moderation are essential for metabolic health [18]. Long-term Benefits - Implementing these strategies can lead to over 60% remission rates within a year, with some patients achieving up to 86% reversal rates. This shift from medication-based management to lifestyle interventions represents a significant advancement in diabetes care [18].

Core Insights - ADM showcased its innovative health solutions at the 15th China International Health Products Exhibition, emphasizing its commitment to future health and scientific empowerment [1][3] - The company introduced two new probiotic combinations, Balance and Restore, to enhance its scientific nutrition product lineup [1][7] Industry Trends - There is a growing consumer demand for functional nutrition, particularly in areas such as weight management, emotional balance, immune support, and gut health [3] - The HNC event serves as a significant platform for industry collaboration and exploration of future nutritional science [3] Product Offerings - ADM presented a range of clinically supported nutritional solutions targeting key health areas for Chinese consumers, including metabolic health, gut health, emotional health, and skin health [4][5] - Specific solutions include probiotics and postbiotics aimed at managing visceral fat, blood sugar levels, and enhancing gut health across various age groups [4][5] Innovation and Technology - The company highlighted its innovative delivery technology, Flashmelt, which offers a superior taste experience and convenience for probiotic consumption [8] - ADM has established a comprehensive turnkey service platform in China, facilitating the entire process from target definition to commercialization [10] Local Development and Global Integration - Celebrating its 30th anniversary in China, ADM has built a robust local strategy encompassing research, innovation, and manufacturing [12] - The company has successfully integrated global innovations into the Chinese market, exemplified by the approval of the DE111 probiotic strain for food use in China [12] Strategic Vision - ADM aims to provide more than just raw materials by leveraging scientific validation and local R&D to enhance product value and reduce development cycles [13]

Core Viewpoint - China has the highest number of overweight and obese individuals globally, with over half of the adult population affected, leading to significant health concerns and potential market opportunities for weight loss solutions [1][2]. Group 1: Obesity Statistics - As of 2021, 16.4% of adults in China are classified as obese, while 34.3% are overweight, totaling approximately 532 million individuals, with nearly 100 million being obese [1]. - A 2020 study predicts that by 2030, the number of overweight adults in China will reach 540 million, and the obese population will increase to 150 million, representing growth of 2.8 times and 7.5 times, respectively, since 2000 [1]. Group 2: Medication Usage and Compliance - Semaglutide, a GLP-1 receptor agonist, has transformed the weight loss market, but many users discontinue its use after a period [2]. - Research indicates that 44% of patients remain on semaglutide after three months, 33% after six months, and only 19% after one year. In contrast, 63%, 56%, and 40% of semaglutide users continue after three months, six months, and one year, respectively [4]. Group 3: Effects of Discontinuation - A clinical trial showed that participants lost an average of 10.6% of their body weight during 20 weeks of semaglutide treatment, but those who switched to a placebo regained an average of 6.9% of their weight, while those who continued with semaglutide lost an additional 7.9% [5]. - An observational study found that 18% of patients regained their lost weight after one year off semaglutide, with 26% regaining more than 25% of their lost weight, while 56% maintained or continued to lose weight [5]. Group 4: Reasons for Discontinuation - Common side effects of GLP-1RA drugs include nausea, diarrhea, and vomiting, which may lead to discontinuation. Even at low doses, 17% of patients reported nausea, with higher rates of gastrointestinal issues at increased doses [6]. - Supply issues have also contributed to discontinuation, as semaglutide has been in short supply since 2022 [7]. - Other reasons for stopping include reaching a weight loss plateau or achieving target weight [9][10]. Group 5: Recommendations for Discontinuation - Gradual dose reduction is recommended to minimize rebound hunger and maintain weight loss. Patients should monitor their appetite and weight closely after discontinuation [11][14]. - Maintaining a healthy lifestyle post-medication is crucial to prevent weight regain, as obesity is a chronic condition requiring ongoing management [22]. Group 6: Lifestyle Management - The latest Chinese weight loss guidelines emphasize lifestyle interventions, including dietary management, exercise, and behavioral changes, as essential for long-term weight management [15]. - Dietary management aims to reduce caloric intake while improving metabolic health, with various dietary patterns showing short-term weight loss effects [16][18]. - Exercise plays a significant role in maintaining weight loss and improving quality of life, despite only achieving modest weight reductions on its own [19]. - Behavioral management is critical for successful weight loss, with structured programs showing significant weight reduction in the initial months [20][21].